Folate Repletion after Deficiency Induces Irreversible Genomic and Transcriptional Changes in Human Papillomavirus Type 16 (HPV16)-Immortalized Human Keratinocytes

被引:9
|
作者
Savini, Claudia [1 ]
Yang, Ruwen [1 ]
Savelyeva, Larisa [2 ]
Goeckel-Krzikalla, Elke [1 ]
Hotz-Wagenblatt, Agnes [3 ]
Westermann, Frank [2 ]
Roesl, Frank [1 ]
机构
[1] German Canc Res Ctr, Div Viral Transformat Mech, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Div Neuroblastoma Genom, D-69120 Heidelberg, Germany
[3] German Canc Res Ctr, Om IT & Data Management, D-69120 Heidelberg, Germany
关键词
human papillomavirus; anogenital cancer; karyotype; genomics; transcriptomics; micronutrients; NUCLEAR RIBONUCLEOPROTEIN E1; IN-VITRO; DNA-DAMAGE; FOLIC-ACID; CANCER; EXPRESSION; TRANSFORMATION; INSTABILITY; INTEGRATION; ASSOCIATION;
D O I
10.3390/ijms20051100
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Supplementation of micronutrients like folate is a double-edged sword in terms of their ambivalent role in cell metabolism. Although several epidemiological studies support a protective role of folate in carcinogenesis, there are also data arguing for an opposite effect. To address this issue in the context of human papillomavirus (HPV)-induced transformation, the molecular events of different folate availability on human keratinocytes immortalized by HPV16 E6 and E7 oncoproteins were examined. Several sublines were established: Control (4.5 mu M folate), folate deficient (0.002 mu M folate), and repleted cells (4.5 mu M folate). Cells were analyzed in terms of oncogene expression, DNA damage and repair, karyotype changes, whole-genome sequencing, and transcriptomics. Here we show that folate depletion irreversibly induces DNA damage, impairment of DNA repair fidelity, and unique chromosomal alterations. Repleted cells additionally underwent growth advantage and enhanced clonogenicity, while the above mentioned impaired molecular properties became even more pronounced. Overall, it appears that a period of folate deficiency followed by repletion can shape immortalized cells toward an anomalous phenotype, thereby potentially contributing to carcinogenesis. These observations should elicit questions and inquiries for broader additional studies regarding folate fortification programs, especially in developing countries with micronutrient deficiencies and high HPV prevalence.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Human papillomavirus type distribution and HPV16 intratype diversity in southern Brazil in women with and without cervical lesions
    de Oliveira, Gisele R.
    Vieira, Valdimara C.
    Avila, Emiliana C.
    Finger-Jardim, Fabiana
    Caldeira, Thais D. M.
    Gatti, Fabiane A. A.
    Goncalves, Carla V.
    Oliveira, Sandro G.
    da Hora, Vanusa P.
    Soares, Marcelo A.
    de Martinez, Ana M. B.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2017, 112 (07): : 492 - 498
  • [22] Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains
    Krul, MRL
    Tijhaar, EJ
    Kleijne, JAFW
    VanLoon, AM
    Nievers, MG
    Schipper, H
    Geerse, L
    VanderKolk, M
    Steerenberg, PA
    Mooi, FR
    DenOtter, W
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (01) : 44 - 48
  • [23] Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy
    Leng, C. Y.
    Low, H. C.
    Chua, L. L.
    Chong, M. L.
    Sulaiman, H.
    Azwa, I.
    Roberts, J. M.
    Kamarulzaman, A.
    Rajasuriar, R.
    Woo, Y. L.
    HIV MEDICINE, 2017, 18 (05) : 321 - 331
  • [24] Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: Adjuvant treatment of minimal residual disease after surgery/chemotherapy
    Bubenik, J.
    Simova, J.
    JOURNAL OF BUON, 2009, 14 : S169 - S173
  • [25] Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies
    Wang, Joshua W.
    Jagu, Subhashini
    Wu, Wai-Hong
    Viscidi, Raphael P.
    Macgregor-Das, Anne
    Fogel, Jessica M.
    Kwak, Kihyuck
    Daayana, Sai
    Kitchener, Henry
    Stern, Peter L.
    Gravitt, Patti E.
    Trimble, Cornelia L.
    Roden, Richard B. S.
    CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (07) : 806 - 816
  • [26] The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer
    Shaw, Richard
    Robinson, Max
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2011, 49 (06) : 423 - 429
  • [27] HPV16 E7 Protein and hTERT Proteins Defective for Telomere Maintenance Cooperate to Immortalize Human Keratinocytes
    Miller, Jonathan
    Dakic, Aleksandra
    Chen, Renxiang
    Palechor-Ceron, Nancy
    Dai, Yuhai
    Kallakury, Bhaskar
    Schlegel, Richard
    Liu, Xuefeng
    PLOS PATHOGENS, 2013, 9 (04)
  • [28] Elimination of high-risk human papillomavirus type HPV16 infection by 'Praneem' polyherbal tablet in women with early cervical intraepithelial lesions
    Shukla, Shirish
    Bharti, Alok C.
    Hussain, Showket
    Mahata, Sutapa
    Hedau, Suresh
    Kailash, Uma
    Kashyap, Veena
    Bhambhani, Suresh
    Roy, Meera
    Batra, Swaraj
    Talwar, G. P.
    Das, Bhudev C.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (12) : 1701 - 1709
  • [29] Evaluation of a Prototype Real-Time PCR Assay for Carcinogenic Human Papillomavirus (HPV) Detection and Simultaneous HPV Genotype 16 (HPV16) and HPV18 Genotyping
    Castle, Philip E.
    Sadorra, Mark
    Lau, Tiffany
    Aldrich, Carrie
    Garcia, Francisco A. R.
    Kornegay, Janet
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (10) : 3344 - 3347
  • [30] Evaluation of Human Papillomavirus Type Replacement Postvaccination Must Account for Diagnostic Artifacts: Masking of HPV52 by HPV16 in Anogenital Specimens
    Tota, Joseph E.
    Ramanakumar, Agnihotram V.
    Villa, Luisa L.
    Richardson, Harriet
    Burchell, Ann N.
    Koushik, Anita
    Mayrand, Marie-Helene
    Coutlee, Francois
    Franco, Eduardo L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (01) : 286 - 290